Navigation Links
PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
Date:1/9/2008

BOSTON, Jan. 9 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL), a leading global bio/pharmaceutical services organization, today announced that Eduard E. Holdener, M.D., formerly Head of Global Pharmaceutical Development at F. Hoffmann-La Roche, Ltd., has been elected to its Board of Directors.

Dr. Holdener was recently appointed to the role of non-executive Chairman of NovImmune. The biotechnology Company develops new therapeutic agents in the field of immune-related disorders and inflammation.

"With 22 years of biopharmaceutical industry experience, which has included managing global operations and overseeing global drug development during the past nine years for a major pharmaceutical company, Dr. Holdener will be an excellent addition to PAREXEL and our Board of Directors," said Josef von Rickenbach, PAREXEL's Chairman and Chief Executive Officer. "Our clients and shareholders will certainly benefit from the extensive expertise Dr. Holdener brings to the Company as we continue to be a premier provider to the biopharmaceutical industry in the development and commercialization of important new therapies worldwide."

In his former role as Global Head of Pharmaceutical Drug Development at Roche, Dr. Holdener successfully led a worldwide development organization, which was instrumental in receiving approvals for key oncology, virology, rheumatology, and anemia drugs in many related indications. He also served as the Company's Chief Medical Officer. During his career with the Company, he helped to establish and expand the oncology therapeutic area, and was presented with the Roche Research and Development Prize in the early 90's. Dr. Holdener led the Company's development operations in Japan fo
'/>"/>

SOURCE PAREXEL
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
2. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities
3. PAREXEL Reports First Quarter Fiscal Year 2008 Financial Results
4. PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call
5. PAREXEL International Updates Financial Guidance in Conjunction with the Acquisition of APEX International Clinical Research Co., Ltd. and Other Factors
6. PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.
7. Parexel Consulting Strengthens Good Manufacturing Practice Capabilities in Europe
8. PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference
9. Quintiles Names Kelly McKee Executive Director of Operations for Public Health and Government Services Unit
10. SRA Names Timothy J. Atkin Senior Vice President of Global Health Business; Appoints Mike Toner Global Health Unit Chief Financial Officer
11. Romark Laboratories Names Emmet B. Keeffe, M.D. Vice President and Chief Medical Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...RNewswire-Asia/ -- Shanghai ChemPartner, as the,fl...based Contract Research,Organization (CRO), today ...nology Fast 50 China, ranking 3rd on the list of t...he award is a testament to ChemPartner,s outstandi..., The results of the 2009 Deloitte Technolo...
(Date:12/1/2009)... level storage is now available to small and mediu... bank. , (PRWEB) December...), a medical imaging software company, announced t... service. The PacsDrive service enables small and ...hive medical imaging in compliance with HIPAA regu...
(Date:12/1/2009)... 1 Aethlon Medical, Inc....t will present at the LD MICRO Conference on Thurs...xe Hotel in Los Angeles. Aethlon Medical,s Chairma...e overview and will provide an update on the compa...emopurifier®, a first-in-class artificial adj...
(Date:12/1/2009)...PRNewswire-FirstCall/ -- Medizone International, I...t in tests involving its proprietary AsepticSure(T...tamination barriers, this time with two very diffe...e and Bacillis subtilis. These results clearly est...icidal technology. "The implications of a 6.7 log ...
Breaking Biology Technology:Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT 2Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2
...reg;, the market and business intelligence company...t estimated at 2.3 billion this year with an annua...ufacturing could account for more than 20% of the ... Paris, France (PRWEB) Septe...om living organisms or their products. The manufac...
...Total Hemoglobin Adhesive ...(Nasdaq:,MASI), the inventor of Pulse CO-Oximetry ... oximetry, today announced,limited release of its ...nd,oxygen content (SpOC(TM)) monitors, Radical-7 a...earance of its latest Rainbow family of adhesive,s...
...,Therapeutics (Nasdaq: FOLD ), a biopharmaceutica...stered pharmacological chaperones for the treatmen...the company has leased,laboratory space for a focu...he facility will be used to support ongoing resear... technology., "With proof of concept for pharmaco...
Other Biology Technology:CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market 2CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market 3Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors 2Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors 3Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors 4Amicus Therapeutics Opens Research Facility in San Diego 2Amicus Therapeutics Opens Research Facility in San Diego 3
(Date:11/30/2009)...ratures continue to rise scientists are presented ...ecies respond and adapt. In a paper published in ...odriguez-Trelles and Dr Miguel Rodriguez assess th... of approximately 0.6˚C has already affected ...ng ecologists and evolutionary biologists is to pr...
(Date:11/30/2009)...e to HIV research is the virus,s exquisite special...s, traditional tools, like the humble lab mouse, c...f researchers writing in BioMed Central,s open acc...sault on this problem by creating a mouse that has...ted with HIV. , George Kassiotis, from the Divis...
(Date:11/30/2009)...report published in the December 2009 print issue ...lar type of control over their fertility that wome...sts have found how and where androgenic hormones w...on and male fertility. This opens a promising aven...discovery also offers hope to those who cannot hav...
Breaking Biology News(10 mins):How can scientists measure evolutionary responses to climate change? 2A reductionist approach to HIV research 2Medelis Expands CRO Services to Medical Devices Appoints Dr Inder Makin as VP 14211 1Medelis Expands CRO Services to Medical Devices Appoints Dr Inder Makin as VP 14211 2Medelis Expands CRO Services to Medical Devices Appoints Dr Inder Makin as VP 14211 3Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 1Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 2Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 3Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 4Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 5Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 6Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 7Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 8Healthcare Reform Must Include Full Participation by Licensed Professional Insurance Agents 57991 1Healthcare Reform Must Include Full Participation by Licensed Professional Insurance Agents 57991 2
...aroos in Argentina. , For David Wake, one of the ...sor of integrative biology at the University of Ca... recent discovery in Korea of a type of salamander...ld, but is totally unknown in Asia and rare outsid...y 50 species of salamanders - more than 10 percent...
... causative agent of anthrax, has been cleared for ...ation (FDA). The test, known as the Gamma Phage As...edical Research Institute of Infectious Diseases (...ty when used with clinical specimens. The original... by the Centers for Disease Control and Prevention...
...unced in Yemen, bringing the reported total number... Yemen had been polio-free since disease surveilla...oing to determine the precise origin of the outbre...e in the immediate future. , Teams of WHO and Mini...remain on the ground, to investigate and control t...
Other Biology News:Discovery of an American salamander where it shouldn't be: Korea 2Discovery of an American salamander where it shouldn't be: Korea 3Discovery of an American salamander where it shouldn't be: Korea 4Anthrax test, developed by army and CDC, receives FDA approval 2Anthrax test, developed by army and CDC, receives FDA approval 3New Vaccine To Be Used For First Time In Polio Outbreak Response 2
...es scientists who do not have access to microarray...re to have their biological samples tested for the...s 1-2-3 Chose the analytes you wish to have quan... Send your samples to be processed to the S&S Cus...
...s an exceptionally sensitive nucleic acid gel stai... and low background in gels, making it ideal for d...ndard UV transilluminators. SYBR Green I nucleic a...phoresis, real-time PCR assays and bandshift assay...
...id gel stain has bright fluorescence when bound to... for detecting dsDNA in gels using laser scanners ...cleic gel acid stain has also found uses in capil...dshift assays. One mL stains 100 minigels. A 500 &...
McCoy's 5A Medium from Sigma-Aldrich
Biology Products: